Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Recent investment activity
KANDO id: 29979
Corporate information
Founders
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Company type
American investment firm focused on making public and private investments in the healthcare and biotechnology industries.Overview
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 114| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Agensys Inc | Series D | ||||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture Follow-on investment | |||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture Follow-on investment | |||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series B | |||
|
|
Biodel Inc | A biopharmaceutical company focused on the development and commercialization of treatments for diabetes | Series B | |||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | Series C | |||
|
|
Adiana Inc | Series D | ||||
|
|
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series C | |||
|
|
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture | |||
|
|
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series B | |||
|
Merrimack Pharmaceuticals Inc | N/A | ||||
|
|
Memory Pharmaceuticals Corp | N/A | ||||
|
|
Caliper Life Sciences Inc | N/A | ||||
|
|
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | N/A | |||
|
|
Vivus Inc | N/A | ||||
|
|
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | |||
|
|
Otic Pharma Ltd | Manufacturer of foam drug delivery system to treat ear disorders. | N/A | |||
|
|
Cerenis Therapeutics SA | N/A | ||||
|
|
Cerapedics Inc | N/A | ||||
|
|
ISIS Pharmaceuticals Inc | N/A | ||||
|
|
Principia Biopharma | Discoverer and developer of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. | N/A | |||
|
|
KIMS GCC | N/A | ||||
|
|
EA Inc | Manufacturer of orthodontics products in China. | N/A | |||
|
|
Realton Corp | Developer of a powerful and cost effective laser systems for use in the treatment of benign prostatic hyperplasia. | N/A | |||
|
|
ChemoCentryx Inc | N/A |